Ads
related to: gleevec side effects gist tumor survival rate- About GIST
Learn more about advanced GIST
and how it may affect your journey.
- GIST Progression
Learn how GIST may progress
even through treatment.
- GIST Mutations & Testing
Learn about GIST mutation
types and how testing may help.
- GIST Journey Support
Find helpful info and resources to
help with your journey with GIST.
- Who Is Treatment For?
See if this treatment for advanced
GIST may be an option for you.
- Are You A Care Partner?
View curated self-care resources
that may help on this journey.
- About GIST
Search results
Results From The WOW.Com Content Network
Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2] Imatinib is a small molecule inhibitor targeting multiple tyrosine kinases such as CSF1R , ABL , c-KIT , FLT3 , and PDGFR-β .
Ripretinib, sold under the brand name Qinlock, is a medication for the treatment of adults with advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract. [3] [4] It is taken by mouth. [3] [4] Ripretinib inhibits the activity of the kinases KIT and PDGFRA, which helps keep cancer cells from ...
[36] [37] The selection criteria underpinning the decision for the possible use of imatinib in these settings, including a risk assessment based on pathological factors such as tumor size, mitotic rate, and location, can be used to predict the risk of recurrence in GIST patients. Tumors <2 cm with a mitotic rate of <5/50 HPF have been shown to ...
Avapritinib, sold under the brand name Ayvakit among others, is a medication used for the treatment of advanced systemic mastocytosis and indolent systemic mastocytosis. It is also used for the treatment of tumors due to one specific rare mutation: it is specifically intended for adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) that harbor a platelet-derived growth ...
Sunitinib, sold under the brand name Sutent, is an anti-cancer medication. [2] It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) in January 2006.
median overall survival time of approximately 12–16 months, with five-year survival rate of approximately 26% and the long-term survival rate of approximately 4 - 5%. Limited-stage small cell lung carcinoma (LS-SCLC) is a type of small cell lung cancer (SCLC) that is confined to an area which is small enough to be encompassed within a ...
Ads
related to: gleevec side effects gist tumor survival rate